Form 13-F position report

MARKER THERAPEUTICS INC

Reported by MORGAN STANLEY

MRKR CUSIP 57055L206 Manager CIK 0000895421

Reported 15 shares, down 445 (96.7%) from the prior quarter.

Reported value -94.6%; share count -96.7% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q4 2025
Shares 15 Quarter-end amount reported
Reported value $22 Fair value at quarter end
Consecutive quarters held 12 Through Q4 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 1377
2023-06-30 6014
2023-09-30 8808
2023-12-31 19790
2024-03-31 17372
2024-06-30 18506
2024-09-30 9611
2024-12-31 1113
2025-03-31 483
2025-06-30 613
2025-09-30 411
2025-12-31 22
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

13 quarters
Quarterly reported position history for MARKER THERAPEUTICS INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -15 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 15 -445 (-96.7%) < 0.01% $22 2026-02-13
Q3 2025 Added 460 +59 (14.7%) < 0.01% $411 2025-11-14
Q2 2025 Added 401 +8 (2.0%) < 0.01% $613 2025-08-15
Q1 2025 Added 393 +35 (9.8%) < 0.01% $483 2025-05-15
Q4 2024 Reduced 358 -3,050 (-89.5%) < 0.01% $1,113 2025-02-14
Q3 2024 Unchanged 3,408 0 (0.0%) < 0.01% $9,611 2024-11-14
Q2 2024 Reduced 3,408 -632 (-15.6%) < 0.01% $18,506 2024-08-14
Q1 2024 Added 4,040 +442 (12.3%) < 0.01% $17,372 2024-05-15
Q4 2023 Added 3,598 +1,658 (85.5%) < 0.01% $19,790 2024-02-13
Q3 2023 Unchanged 1,940 0 (0.0%) < 0.01% $8,808 2023-11-15
Q2 2023 Unchanged 1,940 0 (0.0%) < 0.01% $6,014 2023-08-14
Q1 2023 New 1,940 +1,940 (0.0%) < 0.01% $1,377 2023-05-15

Who else reported the position

41 managers reported MARKER THERAPEUTICS INC for Q4 2025.

Managers reporting MARKER THERAPEUTICS INC in Q4 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NEA Management Company LLC Unchanged 1,625,678 0 0.12% $2,422,260 12 qtrs
Blue Owl Capital Holdings LP Unchanged 554,250 0 0.25% $825,833 5 qtrs
VANGUARD GROUP INC Added 346,074 +46,293 < 0.01% $515,651 12 qtrs
Aisling Capital Management LP Unchanged 325,370 0 0.1% $484,801 11 qtrs
UBS Group AG Added 174,026 +168,232 < 0.01% $259,299 12 qtrs
NewEdge Advisors LLC New 149,000 +149,000 < 0.01% $222,010 1 qtr
GEODE CAPITAL MANAGEMENT LLC Added 130,344 +34,028 < 0.01% $194,238 12 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 123,650 +17,400 < 0.01% $184,239 12 qtrs
TWO SIGMA INVESTMENTS LP Added 98,141 +61,601 < 0.01% $146,230 2 qtrs
ADVISOR GROUP HOLDINGS INC Added 94,421 +13,340 < 0.01% $140,684 12 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2025
Filed
February 13, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
0
None
15

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.